FDA Inspection 1264395 — Medpace Core Laboratories, LLC

Medpace Core Laboratories, LLC — FEI 3005524314

The FDA completed an inspection of Medpace Core Laboratories, LLC on Mar 4, 2025 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Mar 4, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.